CANNES, France, Sept. 10 – Some two-dozen genomic and pharmaceutical companies, 20 private start-up life sciences firms, one bioethicist, and a gaggle of venture capitalists, financiers, institutional funds, and banks descended on this Mediterranean city on Sunday to learn what the future of life sciences may look like and, hopefully, to do deals.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.